Metagenomi Therapeutics, Inc. (MGX) vs Sangamo Therapeutics, Inc. (SGMOQ)
Metagenomi Therapeutics, Inc. and Sangamo Therapeutics, Inc. are both Biotechnology companies. Metagenomi Therapeutics, Inc. and Sangamo Therapeutics, Inc. are of similar size ($43.4M and $41.9M). Sangamo Therapeutics, Inc. grew revenue faster over the last twelve months: −45.8% against −59.8%. Sangamo Therapeutics, Inc. has the higher net margin (−356.9% vs −689.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Sangamo Therapeutics, Inc. leads on 9 and Metagenomi Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | MGX | SGMOQ | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (741.58%) | (357.55%) | 0.00% |
| Net margin | (689.20%) | (356.89%) | 0.00% |
| Free cash flow margin | (632.67%) | (261.76%) | 0.00% |
| Return on equity | (60.61%) | 1,755.72% | (57.72%) |
| Return on assets | (41.91%) | (168.79%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack